Celularity, Inc. (CELU) vs Dogwood Therapeutics, Inc (DWTX)

Celularity, Inc. and Dogwood Therapeutics, Inc are both Biotechnology companies. Celularity, Inc. and Dogwood Therapeutics, Inc are of similar size ($43.2M and $42.5M). Dogwood Therapeutics, Inc has the higher net margin (0.00% vs −375.9%) and the higher return on invested capital (−41.2% vs −695.7%). Across the 12 metrics below, Dogwood Therapeutics, Inc leads on 7 and Celularity, Inc. on 5.

Valuation

Metric CELU DWTX Biotechnology median
P/E n/m n/m 8.50
P/S 1.92 n/m 9.71
P/B n/m 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.06 n/m 9.21
Earnings yield (217.31%) (733.61%) (33.15%)
Free cash flow yield (24.70%) (36.28%) (25.50%)

Profitability

Metric CELU DWTX Biotechnology median
Gross margin 5.26% — 65.16%
Operating margin (321.32%) 0.00% 0.00%
Net margin (375.89%) 0.00% 0.00%
Free cash flow margin (46.46%) 0.00% 0.00%
Return on equity 349.83% (143.45%) (56.36%)
Return on assets (62.45%) (40.68%) (48.04%)
Return on invested capital (695.71%) (41.22%) 0.00%

Growth

Metric CELU DWTX Biotechnology median
Revenue growth (TTM) (62.78%) — 6.02%
EPS growth (last fiscal year) (35.71%) 43.05% 30.26%
Revenue growth, 5-year CAGR 13.21% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELU DWTX Biotechnology median
Debt to equity (1.17) 0.00 0.00
Current ratio 0.09 3.89 4.72
Net debt to EBITDA (0.77) 0.23 0.96

Dividend

Metric CELU DWTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CELU DWTX Biotechnology median
Market cap 43.16m 42.49m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack